The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.941%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 69.00
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

16 Mar 2010 12:25

RNS Number : 6599I
Scientific Digital Imaging Plc
16 March 2010
 



16 March 2010

SCIENTIFIC DIGITAL IMAGING PLC

("SDI", "the Company" or "the Group")

Directorate Changes

SDI is pleased to announce the appointment of Dr Ann Simon and Ken Ford to its Board as non-executive Directors with immediate effect.

Ann Simon has worked in finance, particularly in the healthcare and technology sectors, since 1985. She is presently Chief Financial Officer of Sphere Medical Holding plc. Over the last decade she has been CFO of Genosis plc, Mirada Solutions, NextGen Sciences, e-San and Bioglan Pharma. She has managed IPOs (London full list and AIM), corporate acquisitions and trade sales and fund raisings in the public and private markets. Prior to that she undertook corporate finance advisory work at Cazenove & Co. over a period of more than ten years for clients ranging from start-ups to FTSE100 companies. She was on the FSA's Financial Information Theme Team from 2002 to 2003. Dr Simon will serve as chairman of the Audit Committee.

Ken Ford was previously Chief Executive of Teather & Greenwood the investment bank, becoming Deputy Chairman and Chairman of Corporate Finance in 2004, and brings over 36 years City experience to the Company, including a strong understanding of shareholder value, strategic planning and corporate transactions. Mr Ford was Chairman of the UK Society of Investment Analysts between 1985 - 1987, is a former Chairman of the Quoted Company's Alliance (QCA) and a former member of the EU Advisory Committee to the Corporation of London. Ken's previous directorships include Aberdeen Asset Management, Morgan Grenfell and Wedd Durlacher. Ken is currently a director at AIM-listed companies BrainJuicer Group and Highams Systems Services Group.

As previously announced, Mr. Alf Vaisey will retire from the Board at the end of March.

Harry Tee CBE, Chairman of SDI, commented:

"I am delighted to be able to announce the appointment of two such capable individuals to the Board. I'm sure they will make a great contribution to the furtherance of the Group's strategy."

Other disclosable information

Ann Juliet Bateman Simon, aged 56, is or has been a director of the following companies during the last five years:

Current directorships

Past directorships

Sphere Medical Holding plc

Endace Europe Limited

Sphere Medical Limited

e-San Limited

The Mirada Shareholder Representative Company Limited

e-San Holdings Limited

Genosis PLC

Genosis (UK) Limited

Dr Simon resigned as a director of Bioglan Laboratories Ltd on 14 February 2001 and as a director of Bioglan Pharma Plc and Bioglan (Holdings) Ltd on 1 November 2001. Receivers were appointed in respect of Bioglan Laboratories Ltd, administrators were appointed in respect of Bioglan Pharma Plc and administrators were appointed in respect of Bioglan (Holdings) Ltd all on 21 February 2002. On 27 February 2003, the joint liquidators stated in a letter to creditors of Bioglan Pharma Plc and Bioglan (Holdings) Ltd that the indebtedness due to the secured creditors of those companies was in excess of £113 million and that they anticipated a shortfall of £75 million to those creditors. The joint liquidators also stated at that time that due to the shortfall to the secured creditors there would not be sufficient funds for a dividend to unsecured creditors and consequently that there would be no return to shareholders.

There are no further disclosures to be made regarding this appointment under Schedule 2 paragraph (g) of the AIM rules.

Eric Kenelm Ford, (Ken Ford), aged 60, is or has been a director of the following companies during the last five years:

Current directorships

Past directorships

Brainjuicer Limited

Atlantic Coal plc

BrainJuicer Group plc

Camomile Wood Nominees Limited

Flying Kiwi Inns Limited

Escalon Investments Limited

Highams Systems Services Group plc

Flying Kiwi (Holdings) limited

Lewis Communications Limited

Landsbanki Securities (UK) Holdings plc

Lewis Communications (Holdings) Limited

Teather and Greenwood Nominees Limited

Mintonview Limited

Teathers limited

Principal Residential Properties Limited

Teawood Nominees Limited

7Safe Limited

 

By Board Notice 431 dated 16 July 1997 the Securities and Futures Authority ("SFA") gave notice that disciplinary proceedings brought against Teather & Greenwood Limited Partnership (of which Mr Ford was a partner) and Mr Ford relating to breaches of the Securities and Investment Board Principles 2 and 9 had been concluded by Settlement with the following outcome:

a) Teather & Greenwood Limited Partnership was reprimanded, fined £50,000 and agreed to pay a contribution of £10,000 towards SFA's costs; and

b) Mr Ford was reprimanded, fined £8,000 and agreed to pay a contribution of £2,000 towards SFA's costs.

 SFA took into account that Teather & Greenwood Limited Partnership had previously conducted a full internal review of its compliance procedures and had implemented a remedial action plan. SFA also took into account that neither Teather & Greenwood Partnership nor Mr Ford has previously been the subject of disciplinary action, both cooperated with SFA and no clients had been disadvantaged. Mr Ford was also reprimanded by the Securities Institute as a result.

There are no further disclosures to be made regarding this appointment under Schedule 2 paragraph (g) of the AIM rules.

--END--

FOR FURTHER INFORMATION

Scientific Digital Imaging plc 01223 727144

Harry Tee CBE, Chairman

Phil Atkin, CEO

www.scientificdigitalimaging.com 

Grant Thornton Corporate Finance (Nominated Advisor) 020 7383 5100

Philip Secrett

Colin Aaronson

Astaire Securities plc 020 7448 4400

Katie Shelton

 

Bishopsgate Communications 020 7562 3350

Will Tindall

Gemma O'Hara

sdi@bishopsgatecommunications.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUBGWUPUGPQ
Date   Source Headline
19th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
13th Jan 20215:20 pmRNSExercise of Options and Total Voting Rights
12th Jan 20217:23 amRNSProgressive publishes new research
5th Jan 20217:00 amRNSExercise of Options and Total Voting Rights
10th Dec 202010:20 amRNSDirector Dealing
10th Dec 20207:00 amRNSInvestor Presentation
9th Dec 20207:00 amRNSInterim Results
7th Dec 202011:06 amRNSSecond Price Monitoring Extn
7th Dec 202011:01 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amRNSAcquisition of Monmouth Scientific Limited & TVR
26th Nov 20204:50 pmRNSExercise of Options and Total Voting Rights
28th Oct 20202:23 pmRNSChange of Website
22nd Oct 20207:00 amRNSTrading Update
23rd Sep 20202:06 pmRNSSecond Price Monitoring Extn
23rd Sep 20202:00 pmRNSPrice Monitoring Extension
23rd Sep 202011:40 amRNSResult of AGM
23rd Sep 20207:00 amRNSAGM Trading Update & Investor Meet Company Q&A
3rd Sep 20204:24 pmRNSExercise of Options and Total Voting Rights
26th Aug 20204:49 pmRNSPosting of AR&A and Notice of AGM - Replacement
26th Aug 20204:11 pmRNSPosting of AR&A and Notice of AGM
17th Aug 20204:36 pmRNSPrice Monitoring Extension
21st Jul 20202:06 pmRNSSecond Price Monitoring Extn
21st Jul 20202:00 pmRNSPrice Monitoring Extension
21st Jul 202010:51 amRNSDirector Dealing
21st Jul 20207:01 amRNSInvestor Presentation
21st Jul 20207:00 amRNSFinal Results
9th Jul 20207:00 amRNSNotice of Results
26th May 20202:06 pmRNSSecond Price Monitoring Extn
26th May 20202:00 pmRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSTrading & COVID-19 Update
20th Mar 20207:00 amRNSDirector/PDMR Shareholding
9th Mar 20203:10 pmRNSHolding(s) in Company
31st Jan 20201:19 pmRNSHolding(s) in Company
24th Jan 20203:29 pmRNSExercise of Options
27th Dec 20199:30 amRNSHolding(s) in Company
19th Dec 20191:14 pmRNSDirector/PDMR Shareholding
17th Dec 20197:00 amRNSInterim Results
2nd Dec 20197:00 amRNSAcquisition
31st Oct 20197:00 amRNSChange of Name
9th Oct 201910:43 amRNSExercise of Options
25th Sep 20194:55 pmRNSResult of AGM
25th Sep 20197:00 amRNSAGM Trading Update
20th Sep 20191:15 pmRNSDate of Annual General Meeting
3rd Sep 20195:46 pmRNSPosting of Annual Report and Notice of AGM
22nd Jul 20197:04 amRNSDirector/PDMR Shareholding
18th Jul 20197:00 amRNSFinal Results
27th Jun 20197:00 amRNSTrading Update
15th May 20197:00 amRNSTrading Update
9th May 20197:00 amRNSSDI to present at Mello 2019
5th Apr 201911:02 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.